Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Samaneh Sepahi, Lily Kiaei, Mahmoud Kiaei & Adel Ghorani-Azam. (2023) A systematic review of emerging technologies to enhance the treatment of ovarian cancer. Pharmaceutical Development and Technology 28:7, pages 660-677.
Read now
Read now
Jennifer Thayanne Cavalcante de Araújo, Jonatas Lobato Duarte, Leonardo Delello Di Filippo, Victor Hugo Sousa Araújo, Gabriela Corrêa Carvalho & Marlus Chorilli. (2021) Nanosystem functionalization strategies for prostate cancer treatment: a review. Journal of Drug Targeting 29:8, pages 808-821.
Read now
Read now
Swati Gupta, Yashwant Pathak, Manish K. Gupta & Suresh P. Vyas. (2019) RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 4066-4088.
Read now
Read now
Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Read now
Oliver Lloyd-Parry, Charlotte Downing, Eisa Aleisaei, Celine Jones & Kevin Coward. (2018) Nanomedicine applications in women’s health: state of the art. International Journal of Nanomedicine 13, pages 1963-1983.
Read now
Read now
Zhe Chen, Yuanqiang Zheng, Yanchun Shi & Zhengrong Cui. (2018) Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles. International Journal of Nanomedicine 13, pages 319-336.
Read now
Read now
Muhammad Hassan Safdar, Zahid Hussain, Mohammed A. S. Abourehab, Humna Hasan, Sajal Afzal & Hnin Ei Thu. (2018) New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improved anticancer efficacy. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 1967-1980.
Read now
Read now
Peijun You, Ran Yuan & Chuanyu Chen. (2017) Design and evaluation of lidocaine- and prilocaine-coloaded nanoparticulate drug delivery systems for topical anesthetic analgesic therapy: a comparison between solid lipid nanoparticles and nanostructured lipid carriers. Drug Design, Development and Therapy 11, pages 2743-2752.
Read now
Read now
Yinan Zhong, Fenghua Meng, Chao Deng, Xinliang Mao & Zhiyuan Zhong. (2017) Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles. Drug Delivery 24:1, pages 1482-1490.
Read now
Read now
Articles from other publishers (29)
Karthikeyan Elumalai, Sivaneswari Srinivasan & Anandakumar Shanmugam. (2024) Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment. Biomedical Technology 5, pages 109-122.
Crossref
Crossref
Kelsey L. Swingle, Adele S. Ricciardi, William H. Peranteau & Michael J. Mitchell. (2023) Delivery technologies for women’s health applications. Nature Reviews Bioengineering 1:6, pages 408-425.
Crossref
Crossref
Praharsh Kumar Mandadhi Rajendra, Bala Sai Soujith Nidamanuri, Akey Krishna Swaroop, Janani Selvam Krishnamurali, Anjali Puthusserikkunnu Balan, Jubie Selvaraj, Rajeshkumar Raman, Hagalavadi Nanjappa Shivakumar, Murthannagari Vivek Reddy & Natarajan Jawahar. (2023) Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach. Journal of Drug Delivery Science and Technology 81, pages 104270.
Crossref
Crossref
Obaid Afzal, Abdulmalik S. A. Altamimi, Muhammad Shahid Nadeem, Sami I. Alzarea, Waleed Hassan Almalki, Aqsa Tariq, Bismillah Mubeen, Bibi Nazia Murtaza, Saima Iftikhar, Naeem Riaz & Imran Kazmi. (2022) Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials 12:24, pages 4494.
Crossref
Crossref
Hanaa Ali Hussein & Mohd Azmuddin Abdullah. (2021) Novel drug delivery systems based on silver nanoparticles, hyaluronic acid, lipid nanoparticles and liposomes for cancer treatment. Applied Nanoscience 12:11, pages 3071-3096.
Crossref
Crossref
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg & Hugo Albrecht. (2022) Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers 14:10, pages 2362.
Crossref
Crossref
Agnese Gagliardi, Roberto Molinaro, Massimo Fresta, Andrea Duranti & Donato Cosco. (2022) α-Acylamino-β-lactone N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors Encapsulated in PLGA Nanoparticles: Improvement of the Physical Stability and Protection of Human Cells from Hydrogen Peroxide-Induced Oxidative Stress. Antioxidants 11:4, pages 686.
Crossref
Crossref
Zhe Wang, Fenghua Meng & Zhiyuan Zhong. (2021) Emerging targeted drug delivery strategies toward ovarian cancer. Advanced Drug Delivery Reviews 178, pages 113969.
Crossref
Crossref
Mariana Nunes, Patrícia M. A. Silva, Ricardo Coelho, Carla Pinto, Albina Resende, Hassan Bousbaa, Gabriela M. Almeida & Sara Ricardo. (2021) Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. Frontiers in Oncology 11.
Crossref
Crossref
Rodrigo Cé, Vladimir Lavayen, Gabriela Klein Couto, João Guilherme Barreto De Marchi, Barbara Zoche Pacheco, Letícia Antunes Natividade, Tiago Ost Fracari, Taiane Medeiro Ciocheta, Aline de Cristo Soares Alves, Denise Soledade Jornada, Silvia Stanisçuaski Guterres, Fabiana Seixas, Tiago Collares & Adriana Raffin Pohlmann. (2021) Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines. Pharmaceutical Research 38:2, pages 301-317.
Crossref
Crossref
Siwan Wang, Hui Jiang, Jia Wang, Haisi Wu, Ting Wu, Mengnan Ni, Qianqian Zhao, You Ji, Ziting Zhang, Chunming Tang & Huae Xu. (2021) Superior <i>in vitro</i> anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer. The Journal of Biomedical Research 35:4, pages 327.
Crossref
Crossref
Yuan Li, Yan Gao, Xi Zhang, Hongyan Guo & Huile Gao. (2020) Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy. International Journal of Pharmaceutics 591, pages 119986.
Crossref
Crossref
Yi Zhu, Guonan Zhang, Meiying Li, Lang Ma, Jianming Huang & Li Qiu. (2020) Ultrasound-Augmented Phase Transition Nanobubbles for Targeted Treatment of Paclitaxel-Resistant Cancer. Bioconjugate Chemistry 31:8, pages 2008-2020.
Crossref
Crossref
Hui Zhao, Aixia Wang & Zhiwei Zhang. (2020) LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465. The Journal of Biochemistry 168:2, pages 171-181.
Crossref
Crossref
Huaiyu Zhang, Shujun Dong, Zhongmin Li, Xiangru Feng, Weiguo Xu, Catrina Mae S. Tulinao, Yang Jiang & Jianxun Ding. (2020) Biointerface engineering nanoplatforms for cancer-targeted drug delivery. Asian Journal of Pharmaceutical Sciences 15:4, pages 397-415.
Crossref
Crossref
Marcela Tavares Luiz, Juliana Palma Abriata, Giovanni Loureiro Raspantini, Larissa Bueno Tofani, Fernando Fumagalli, Shaiani Maria Gil de Melo, Flavio da Silva Emery, Kamilla Swiech, Priscyla Daniely Marcato, Robert Lee & Juliana Maldonado Marchetti. (2019) In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy. Materials Science and Engineering: C 105, pages 110038.
Crossref
Crossref
Alaa M. Khalifa, Manal A. Elsheikh, Amr M. Khalifa & Yosra S.R. Elnaggar. (2019) Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article. Journal of Controlled Release 311-312, pages 125-137.
Crossref
Crossref
P.L. Reshma, B.S. Unnikrishnan, G.U. Preethi, H.P. Syama, M.G. Archana, K. Remya, R. Shiji, J. Sreekutty & T.T. Sreelekha. (2019) Overcoming drug-resistance in lung cancer cells by paclitaxel loaded galactoxyloglucan nanoparticles. International Journal of Biological Macromolecules 136, pages 266-274.
Crossref
Crossref
Jing Tang, Yunxia Wang, Yi Li, Yang Zhang, Runyuan Zhang, Ziyu Xiao, Yongchao Luo, Xueying Guo, Lin Tao, Yan Lou, Weiwei Xue & Feng Zhu. (2019) Recent Technological Advances in the Mass Spectrometry-based Nanomedicine Studies: An Insight from Nanoproteomics. Current Pharmaceutical Design 25:13, pages 1536-1553.
Crossref
Crossref
Subin Kim, Myeong ju Moon, Suchithra Poilil Surendran & Yong Yeon Jeong. (2019) Biomedical Applications of Hyaluronic Acid-Based Nanomaterials in Hyperthermic Cancer Therapy. Pharmaceutics 11:7, pages 306.
Crossref
Crossref
Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu & Hanqing Liu. (2019) Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy. Current Cancer Drug Targets 19:6, pages 449-467.
Crossref
Crossref
Shiva Mahmoudi, Marjan Ghorbani, Mehdi Sabzichi, Fatemeh Ramezani, Hamed Hamishehkar & Nasser Samadi. (2019) Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells. Journal of Drug Delivery Science and Technology 49, pages 268-276.
Crossref
Crossref
Hoon Hyun, Min Park, Gayoung Jo, So Kim, Heung Chun & Dae Yang. (2019) Photo-Cured Glycol Chitosan Hydrogel for Ovarian Cancer Drug Delivery. Marine Drugs 17:1, pages 41.
Crossref
Crossref
Elisa Gaio, Claudia Conte, Diletta Esposito, Giovanni Miotto, Fabiana Quaglia, Francesca Moret & Elena Reddi. (2018) Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells. Molecular Pharmaceutics 15:10, pages 4599-4611.
Crossref
Crossref
Gangliang Huang & Hualiang Huang. (2018) Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system. Journal of Controlled Release 278, pages 122-126.
Crossref
Crossref
Maciej Nowacki, Margarita Peterson, Tomasz Kloskowski, Eleanor McCabe, Delia Cortes Guiral, Karol Polom, Katarzyna Pietkun, Barbara Zegarska, Marta Pokrywczynska, Tomasz Drewa, Franco Roviello, Edward A. Medina, Samy L. Habib & Wojciech Zegarski. (2017) Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. Oncotarget 8:44, pages 78208-78224.
Crossref
Crossref
Xin Yin, Su-Su Zheng, Lan Zhang, Xiao-Ying Xie, Yan Wang, Bo-Heng Zhang, Weizhong Wu, Shuangjian Qiu & Zheng-Gang Ren. (2017) Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells. Gene 596, pages 53-88.
Crossref
Crossref
Mariacristina Gagliardi. (2016) Novel biodegradable nanocarriers for enhanced drug delivery. Therapeutic Delivery 7:12, pages 809-826.
Crossref
Crossref
Ana Cadete & María José Alonso. (2016) Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives. Nanomedicine 11:17, pages 2341-2357.
Crossref
Crossref